Literature DB >> 1147902

Stimulation of the pathway of porphyrin synthesis in the liver of rats and mice by griseofulvin, 3,5-Diethoxycarbonyl-1,4-dihydrocollidine and related drugs: evidence for two basically different mechanisms.

F De Matteis, A H Gibbs.   

Abstract

Griseofulvin and isogriseofulvin cause, like 3,5-diethoxycarbonyl-1,4-dihydrocollidine, a fall in the activity of the hepatic enzyme porphyrin-metal chelatase and accumulation of protoporphyrin in the liver. Analogues of either griseofulvin or 3,5-diethoxycarbonyl-1,4-dihydrocollidine which do not decrease the chelatase activity are not porphyrogenic on their own, but can potentiate the porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. This suggests the existence of two basically different mechanisms by which drugs stimulate the pathway of porphyrin synthesis in the liver.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1147902      PMCID: PMC1165300          DOI: 10.1042/bj1460285

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  16 in total

1.  Effects of diethyl-1, 4-dihydro-2, 4,6-trimethylpyridine-3,5-dicarboxylate on the metabolism of porphyrins and iron.

Authors:  J ONISAWA; R F LABBE
Journal:  J Biol Chem       Date:  1963-02       Impact factor: 5.157

2.  Spectrophotofluorometric assay of griseofulvin.

Authors:  C BEDFORD; K J CHILD; E G TOMICH
Journal:  Nature       Date:  1959-08-01       Impact factor: 49.962

Review 3.  Experimental porphyria.

Authors:  D P Tschudy; H L Bonkowsky
Journal:  Fed Proc       Date:  1972 Jan-Feb

4.  Drug interactions in experimental hepatic porphyria. A model for the exacerbation by drugs of human variegate porphyria.

Authors:  F De Matteis
Journal:  Enzyme       Date:  1973

5.  Drug-induced porphyrin biosynthesis. IV. Investigation of the differences in response of isolated liver cells and the liver of the intact chick embryo to porphyria-inducing drugs.

Authors:  W J Racz; G S Marks
Journal:  Biochem Pharmacol       Date:  1972-01-15       Impact factor: 5.858

6.  Drugs and porphyria.

Authors:  F De Matteis
Journal:  S Afr Med J       Date:  1971-09-25

7.  Regulation of delta-aminolevulinic acid synthetase by drugs and steroids in isolated perfused rat liver.

Authors:  K W Bock; R Weiner; W Fröhling
Journal:  Enzyme       Date:  1973

8.  Decreased levels of cytochrome P-450 and catalase in hepatic porphyria caused by substituted acetamides and barbiturates. Importance of the allyl group in the molecule of the active drugs.

Authors:  G Abbritti; F De Matteis
Journal:  Chem Biol Interact       Date:  1972-03       Impact factor: 5.192

9.  A model for the regulation of delta-aminolaevulinate synthetase induction in rat liver.

Authors:  G Padmanaban; M R Rao; K Malathi
Journal:  Biochem J       Date:  1973-08       Impact factor: 3.857

10.  Stimulation of liver 5-aminolaevulinate synthetase by drugs and its relevance to drug-induced accumulation of cytochrome P-450. Studies with phenylbutazone and 3,5-diethoxycarbonyl-1,4-dihydrocollidine.

Authors:  F De Matteis; A Gibbs
Journal:  Biochem J       Date:  1972-03       Impact factor: 3.857

View more
  13 in total

1.  The effects of acetate, metal cations, phenobarbitone, porphyrogens and substrates of glycine acyltransferase on the utilization of haem by rat liver apo-(tryptophan pyrrolase).

Authors:  A A Badawy
Journal:  Biochem J       Date:  1977-05-15       Impact factor: 3.857

2.  Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool.

Authors:  Reginald Davies; Arenda Schuurman; Colin R Barker; Bruce Clothier; Tatyana Chernova; Fiona M Higginson; David J Judah; David Dinsdale; Richard E Edwards; Peter Greaves; Timothy W Gant; Andrew G Smith
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

3.  Drug-induced conversion of liver haem into modified porphyrins. Evidence for two classes of products.

Authors:  F De Matteis; A H Gibbs
Journal:  Biochem J       Date:  1980-04-01       Impact factor: 3.857

Review 4.  Cytochrome P450 regulation: the interplay between its heme and apoprotein moieties in synthesis, assembly, repair, and disposal.

Authors:  Maria Almira Correia; Peter R Sinclair; Francesco De Matteis
Journal:  Drug Metab Rev       Date:  2010-09-23       Impact factor: 4.518

5.  Studies on the mechanism of experimental porphyria produced by 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Role of a porphyrin-like inhibitor of protohaem ferro-lyase.

Authors:  T R Tephly; A H Gibbs; F De Matteis
Journal:  Biochem J       Date:  1979-04-15       Impact factor: 3.857

6.  Labelling in vivo and chirality of griseofulvin-derived N-alkylated protoporphyrins.

Authors:  F De Matteis; A H Gibbs; S R Martin; R L Milek
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

7.  Drug-induced accumulation of uroporphyrin in chicken hepatocyte cultures. Structural requirements for the effect and role of exogenous iron.

Authors:  A Ferioli; C Harvey; F De Matteis
Journal:  Biochem J       Date:  1984-12-15       Impact factor: 3.857

8.  Tryptophan pyrrolase, the regulatory free haem and hepatic porphyrias. Early depletion of haem by clinical and experimental exacerbators of porphyria.

Authors:  A A Badawy
Journal:  Biochem J       Date:  1978-06-15       Impact factor: 3.857

9.  Inhibition of ferrochelatase and accumulation of porphyrins in mouse hepatocyte cultures exposed to porphyrinogenic chemicals.

Authors:  A M Brady; E A Lock
Journal:  Arch Toxicol       Date:  1992       Impact factor: 5.153

10.  Inhibition of protohaem ferro-lyase by N-substituted porphyrins. Structural requirements for the inhibitory effect.

Authors:  F De Matteis; A H Gibbs; A G Smith
Journal:  Biochem J       Date:  1980-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.